US Broker Ratings

Immunovant, Inc. (IMVT): Investor Outlook with a 168% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT), a cutting-edge biotechnology company, has caught the attention of investors with its robust potential for significant stock appreciation. Specializing in the development of monoclonal antibodies targeting..

Ascentage Pharma Group Internat (AAPG): Growth Potential Amidst Market Challenges in the Biotechnology Sector

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company based in Suzhou, China, stands as a beacon of innovative research in the healthcare sector. With a market capitalization of $3.97..

Vericel Corporation (VCEL) Stock Analysis: Biotech Innovator with Potential Upside of Over 48%

Vericel Corporation (NASDAQ: VCEL) is a name that stands out in the biotechnology sector, particularly for investors with an eye on the healthcare landscape. With a market capitalization of $1.83..

Edgewise Therapeutics (EWTX) Stock Analysis: A 161% Upside Potential Sparks Investor Interest

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing attention in the biotechnology sector with its promising pipeline aimed at tackling muscle disorders. Based in Boulder, Colorado, this biopharmaceutical company is on..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a Potential 58% Upside in the Biotech Sector

CRISPR Therapeutics AG (NASDAQ: CRSP), a Switzerland-based biotechnology firm, is at the forefront of innovative gene-editing therapies. With a market capitalization of $4.71 billion, CRISPR has captured the attention of..

Disc Medicine, Inc. (IRON) Stock Analysis: A Biotech Gem with a 67% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a burgeoning player in the biotechnology sector, presents an intriguing opportunity for investors with its focus on developing treatments for hematologic diseases. With a market..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A 39% Upside Beckons as Biotech Innovates

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss biotech innovator with a market capitalization of $3.54 billion, is capturing investors’ attention with its promising therapeutic pipeline and significant upside potential. Operating within..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Look at Growth Potential Amid Strong Revenue Gains

Guardian Pharmacy Services, Inc (GRDN), a key player in the healthcare sector’s medical care facilities industry, is making waves with its robust revenue growth and promising analyst ratings. Headquartered in..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Uncovering a 38.85% Potential Upside

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing the attention of investors with its promising growth trajectory in the healthcare sector. Based in the United Kingdom, Kiniksa specializes in developing and..

SS Innovations International (SSII) Stock Analysis: A 121.8% Revenue Growth Story in the Healthcare Sector

SS Innovations International, Inc. (SSII), a healthcare company specializing in medical devices, is capturing the attention of investors with its impressive revenue growth of 121.8%. Based in Gurugram, India, SSII..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Promising 106% Upside Potential in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of the biotechnology sector, offering investors a compelling opportunity with a significant upside potential of 106.29%. The company, headquartered in South..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 39% Upside Potential in the Healthcare Sector

Clover Health Investments, Corp (CLOV), a key player within the healthcare sector, is capturing the attention of investors as it seeks to redefine the landscape of Medicare Advantage plans in..

Galapagos NV (GLPG) Stock Analysis: Evaluating the 19% Downside Potential Amid Biotech Challenges

As Galapagos NV (NASDAQ: GLPG) navigates the complexities of the biotechnology sector, investors are tasked with weighing potential risks against the company’s innovative pursuits. Based in Mechelen, Belgium, Galapagos NV..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 38% Potential Upside with a Strong Buy Consensus

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector known for its innovative medical instruments and supplies, is drawing significant attention from investors. With a market capitalization..

ImmunityBio, Inc. (IBRX) Investor Outlook: Biotech Stock with a 335.90% Upside Potential

ImmunityBio, Inc. (NASDAQ: IBRX), a promising player in the biotechnology sector, is capturing the attention of investors with its cutting-edge innovations in cancer and infectious disease therapies. With a market..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking the 35% Upside Potential with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the medical instruments and supplies industry, is currently garnering significant attention from investors, thanks to its robust growth potential and a unanimous..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A Promising 15.23% Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a notable player in the biotechnology sector, is attracting investor attention with its significant potential upside of 15.23%. Specializing in the development and commercialization of..

UFP Technologies, Inc. (UFPT) Stock Analysis: 56.79% Potential Upside in the Booming Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) has emerged as a standout player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.62 billion, the company..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a 29.74% Potential Upside in Biotech Innovation

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a pioneering force in the biotechnology sector, is making waves with its innovative approach to eye care and infectious disease prevention. The Irvine, California-based company..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a 48.74% Potential Upside in Biotech

Belite Bio, Inc (BLTE) is making waves in the biotechnology sector with its promising portfolio centered on innovative treatments for retinal degenerative diseases. Operating out of San Diego, California, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds